Omixon acquires Organ Monitoring Group BV
HoloGRAFT in comparison with other cell-free DNA analysis methods Omixon to commercialize a cell-free DNA assay for transplant monitoring developed and validated a transplant physician BUDAPEST, HUNGARY, June 4, 2022 /EINPresswire.com/ — Omixon Biocomputing, Kft announced today that it has completed a collaborative agreement with Organ Monitoring Group to develop post-transplant monitoring product HoloGRAFT. […]
The post Omixon acquires Organ Monitoring Group BV first appeared on Amsterdam Aesthetics.